An Israeli research group found that people over the age of 60 who received four doses of the new coronavirus vaccine had a 64% lower risk of hospitalization than those who received three doses.
On the 25th, an Israeli research group analyzed the effects of four doses of Pfizer's new coronavirus vaccine for people over the age of 60 who join one of the Israeli insurance organizations, Clarit. Was announced.
According to this, among those 60 to 100 years old who received the third vaccination for at least 4 months, more than 328,000 people received the fourth vaccination during the 40 days from January 10th. , The number of people who did not receive it was more than 234,000.
Comparing the course of symptoms of these individuals infected with the new coronavirus, those who received the fourth dose had a 64% lower risk of hospitalization and those who received the third dose had a 64% lower risk of dying. That's a 78% drop.
The research group concludes that "the fourth dose of the new coronavirus vaccine has been shown to significantly reduce the risk of hospitalization and death for older people during the Omicron strain epidemic."
The results of this analysis were published in the British medical journal "Nature Medicine" on the 25th.